Category Archives: Deals

Omnicom and Publicis: Musings on the Merger

With the pharma industry spending over $31 billion a year on product promotion, the melding of ad giants Omnicom and Publicis beckons a closer look. The two holding companies lent ink to their union in Paris at the end of last month. Since then, a number of perspectives on the deal have surfaced, many of […]
Also posted in Advertising, Agency Insight, E-Media, Global, Marketing, Strategy | Tagged , , , , , , , , , | Leave a comment

CMS taps IT firm CGI for Sunshine Act Data Dump

Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu Agrawal, director, data sharing and partnership group, center for program integrity, CMS, said the agency hired IT company CGI to build the software platform to be used for publishing pharma payments to physicians under the Sunshine Act provisions, now re-branded “open […]
Also posted in Agency Insight, E-Media, FDA, healthcare, People, Technology | Tagged , , , , , , , , , , , , , , , | Leave a comment

Roche Jumps into Medicines Patent Pool with Pricing and Licensing Deal

Roche this week has announced a partnership with the UN-backed Medicines Patent Pool (MPP) to provide its drug valganciclovir, better known in the developed world as Valcyte, in 138 countries for a reduced price. In addition to making the drug available in these markets for up to 90% cheaper than current price, Roche has decided […]
Also posted in Corporate Responsibility, Emerging Markets, Global, IP, Market Access, pricing | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

J.P. Morgan: Suits Take San Francisco

The perennial fat got chewed during the first two days at J.P. Morgan’s annual healthcare conference – buy back stock or raise dividends? – and the usual suspects lurked, but newcomers like Walgreens and not-so-pharma companies like Life Technologies packed the presentation halls and corridors, demonstrating investor and general interest in new ideas, products and […]
Also posted in Biotech, Events, Global, healthcare, leadership, pricing, R&D, Regulatory, Strategy, Technology | Tagged | Leave a comment

Pharma in the Dell: Working with Academia

How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.
Also posted in Biotech, IP, leadership, Meetings, People, R&D, Strategy, Technology | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta